Literature DB >> 26814296

Burning Eye Syndrome: Do Neuropathic Pain Mechanisms Underlie Chronic Dry Eye?

Jerry P Kalangara1, Anat Galor2, Roy C Levitt3, Elizabeth R Felix4, Ramon Alegret5, Constantine D Sarantopoulos6.   

Abstract

OBJECTIVE: Dry eye is a multi-factorial disorder that manifests with painful ocular symptoms and visual disturbances, which can only be partly attributed to tear dysfunction. This disorder may also involve neuroplasticity in response to neuronal injury. This review will emphasize the key characteristics of dry eye pain and its pathologic mechanisms, making the argument that a subset of dry eye represents a neuropathic pain disorder of the eye, more appropriately called "burning eye syndrome."
METHODS: A literature review was conducted using a PubMed search focusing on dry eye, corneal nociception, and neuropathic pain. Articles were reviewed and those discussing clinical course, pathophysiology, and neuronal regulation of chronic ocular pain as related to dry eye were summarized.
RESULTS: We found that there is a discordance between ocular pain and dryness on the ocular surface. Although tear dysfunction may be one of the initial insults, its persistence may be associated with repeated ocular sensory nerve injury leading to an acute-to-chronic pain transition associated with neuropathologic changes (peripheral and central sensitization), neuronal dysfunction, and spontaneous ocular pain.
CONCLUSION: Dry eye is becoming a major health concern due to its increasing incidence, significant morbidity, and economic burden. Recent evidence suggests that a subset of dry eye may be better represented as a chronic neuropathic pain disorder due to its features of dysesthesia, spontaneous pain, allodynia, and hyperalgesia. Future therapies targeted at the underlying neuroplasticity may yield improved efficacy for patients with this subset of dry eye, which we term "burning eye syndrome."
© 2015 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cornea; Dry Eye; Hyperalgesia; Neuronal Dysfunction; Neuropathic Pain; Sensitization

Mesh:

Year:  2015        PMID: 26814296      PMCID: PMC6281056          DOI: 10.1093/pm/pnv070

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  79 in total

1.  Tear secretion induced by selective stimulation of corneal and conjunctival sensory nerve fibers.

Authors:  M Carmen Acosta; Assumpta Peral; Carolina Luna; Jesús Pintor; Carlos Belmonte; Juana Gallar
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-07       Impact factor: 4.799

Review 2.  Review article: Preventive analgesia: quo vadimus?

Authors:  Joel Katz; Hance Clarke; Ze'ev Seltzer
Journal:  Anesth Analg       Date:  2011-09-30       Impact factor: 5.108

3.  Nerves and sensations from the eye surface.

Authors:  Carlos Belmonte; Adolfo Aracil; M Carmen Acosta; Carolina Luna; Juana Gallar
Journal:  Ocul Surf       Date:  2004-10       Impact factor: 5.033

4.  Chronic (neuropathic) corneal pain and blepharospasm: five case reports.

Authors:  David Borsook; Perry Rosenthal
Journal:  Pain       Date:  2011-07-12       Impact factor: 6.961

5.  Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction.

Authors:  Steven L Maskin
Journal:  Cornea       Date:  2010-10       Impact factor: 2.651

Review 6.  Utility assessment to measure the impact of dry eye disease.

Authors:  Patricia Buchholz; Carolyn S Steeds; Lee S Stern; Daniel P Wiederkehr; John J Doyle; Laura M Katz; Francisco C Figueiredo
Journal:  Ocul Surf       Date:  2006-07       Impact factor: 5.033

7.  The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.

Authors:  Polyxane Mertzanis; Linda Abetz; Krithika Rajagopalan; Derek Espindle; Robin Chalmers; Christopher Snyder; Barbara Caffery; Timothy Edrington; Trefford Simpson; J Daniel Nelson; Carolyn Begley
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

8.  An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye.

Authors:  José M Benítez del Castillo; Mohamed A S Wasfy; Cristina Fernandez; Julian Garcia-Sanchez
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

9.  The cornea in Sjogren's syndrome: an in vivo confocal study.

Authors:  Edoardo Villani; Daniela Galimberti; Francesco Viola; Chiara Mapelli; Roberto Ratiglia
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

Review 10.  Deconstructing the neuropathic pain phenotype to reveal neural mechanisms.

Authors:  Christian A von Hehn; Ralf Baron; Clifford J Woolf
Journal:  Neuron       Date:  2012-02-23       Impact factor: 17.173

View more
  22 in total

1.  Is gabapentin effective in dry eye disease and neuropathic ocular pain?

Authors:  Nedim Ongun; Gulin Tugba Ongun
Journal:  Acta Neurol Belg       Date:  2019-05-27       Impact factor: 2.396

2.  Comparison Between Viscous Teardrops and Saline Solution to Fill Orthokeratology Contact Lenses Before Overnight Wear.

Authors:  Gonzalo Carracedo; Cesar Villa-Collar; Alba Martin-Gil; Maria Serramito; Leticia Santamaría
Journal:  Eye Contact Lens       Date:  2018-09       Impact factor: 2.018

Review 3.  [Intense pulsed light (IPL) as a therapeutic option for Meibomian gland dysfunction].

Authors:  A Schuh; S Priglinger; E M Messmer
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

4.  Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain.

Authors:  Serkan Ozen; Murat Atabey Ozer; Mehmet Orçun Akdemir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-03-15       Impact factor: 3.117

5.  Efficacy of autologous serum tears for treatment of neuropathic corneal pain.

Authors:  Shruti Aggarwal; Clara Colon; Ahmad Kheirkhah; Pedram Hamrah
Journal:  Ocul Surf       Date:  2019-01-24       Impact factor: 5.033

Review 6.  Comprehensive Review and Update of Burning Eye Syndrome.

Authors:  Stephen Giacomazzi; Ivan Urits; Briggs Hoyt; Ashley Hubble; Elyse M Cornett; Kyle Gress; Karina Charipova; Amnon A Berger; Hisham Kassem; Alan D Kaye; Omar Viswanath
Journal:  J Patient Cent Res Rev       Date:  2021-07-19

7.  Capsazepine decreases corneal pain syndrome in severe dry eye disease.

Authors:  Annabelle Réaux-Le Goazigo; Stéphane Mélik Parsadaniantz; Darine Fakih; Adrian Guerrero-Moreno; Christophe Baudouin
Journal:  J Neuroinflammation       Date:  2021-05-11       Impact factor: 8.322

8.  Modification of the Neuropathic Pain Symptom Inventory for use in eye pain (NPSI-Eye).

Authors:  Monika Farhangi; William Feuer; Anat Galor; Didier Bouhassira; Roy C Levitt; Constantine D Sarantopoulos; Elizabeth R Felix
Journal:  Pain       Date:  2019-07       Impact factor: 7.926

9.  Transcutaneous Electrical Nerve Stimulation for the Long-Term Treatment of Ocular Pain.

Authors:  Kristen Zayan; Shruti Aggarwal; Elizabeth Felix; Roy Levitt; Konstantinos Sarantopoulos; Anat Galor
Journal:  Neuromodulation       Date:  2020-03-20

10.  The Relationship Between Ocular Itch, Ocular Pain, and Dry Eye Symptoms (An American Ophthalmological Society Thesis).

Authors:  Anat Galor; Leslie Small; William Feuer; Roy C Levitt; Konstantinos D Sarantopoulos; Gil Yosipovitch
Journal:  Trans Am Ophthalmol Soc       Date:  2018-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.